Omixon Celebrates a Successful EFI 2017

21/06/2017

Thank you to all our friends, customers, co-vendors and distributors for visiting our wonderful new booth, joining our events and just generally hanging out at the 31st annual EFI Meeting in Mannheim, Germany between 30 May-02 June, 2017! Omixon conducted a range of activities, including our very first Distributor...

2017: HLA TWIN V2.1 New Release

03/03/2017

Omixon announce today a major release for HLA Twin – the world’s most accurate, high throughput HLA genotyping software. HLA Twin V2.1 will be available as RUO and a special version will be submitted to the European Notified Body for CE-IVD certification. Thanks to the beta testers of V2.1,...

Omixon Symposium at the Upcoming EWIC 2017 Conference

06/02/2017

Omixon is proud to announce that we are one of the Silver Sponsors of the Annual EWIC 2017 Conference. Marcello Scala (Director of Sales, EMEA) and Dr. Libor Kolesár (Field Application Scientist) will announce major improvements to the existing products during a commercial presentation. Title of the presentation: “Omixon V.2...

2017: An Omixon Odyssey – A Letter from CEO, Tim Hague

30/01/2017

Dear Customers and Friends of Omixon, After a prosperous finish to 2016, I would like you to be the first to know about three major announcements concerning Omixon’s evolution for 2017, in the HLA community and beyond. First, in the next few weeks, we will be launching Holotype...

2016 Omixon Spotlight – This is How We Rolled!

20/12/2016

“2016 will be even more challenging and eventful” – this is how we waved goodbye to 2015, hoping for an amazing and exciting sequel. And holy smoke, what a year we’ve had! We started 2016 with a bang – a national tender victory in France: Holotype HLA, our...